Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic...

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Synucleinopathies (e.g., Parkinson's disease) and amyloidogenic disorders (e.g., Alzheimer's disease) are leading neurodegenerative conditions.
• Distinct protein aggregates (α-synuclein and amyloid-β) characterize these diseases.
• Despite differences, shared molecular pathways are increasingly recognized.

Purpose of the Study:

• To explore the molecular intersections between synucleinopathies and amyloidogenesis.
• To highlight common pathways driving neuronal loss in these disorders.
• To suggest multi-targeted therapies for neurodegenerative diseases.

Main Methods:

• Review of emerging evidence on shared molecular pathways.
• Analysis of common mechanisms in protein misfolding and aggregation.
• Exploration of oxidative stress, neuroinflammation, and mitochondrial dysfunction.

Main Results:

• Identified common molecular pathways in synucleinopathies and amyloidogenic disorders.
• Demonstrated how these shared pathways contribute to neuronal loss.
• Highlighted the potential for targeting these common mechanisms.

Conclusions:

• Shared molecular pathways underscore a common basis for Parkinson's disease and Alzheimer's disease.
• Targeting these intersecting pathways offers potential for broad therapeutic benefits.
• Multi-targeted therapies could provide disease-modifying treatments for neurodegenerative diseases.